Lactobacillus plantarum K8-based paraprobiotics suppress lipid accumulation during adipogenesis by the regulation of JAK/STAT and AMPK signaling pathways
[Display omitted] •The effect of paraprobiotics (LAB-P) on anti-adipogenesis was evaluated.•LAB-P inhibited adipogenesis by inhibiting the key activators PPARγ and C/EBPα.•Its anti-adipogenic effect is related to the regulation of early adipogenic factors.•LAB-P suppresses lipid accumulation by regu...
Gespeichert in:
Veröffentlicht in: | Journal of functional foods 2021-12, Vol.87, p.104824, Article 104824 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
•The effect of paraprobiotics (LAB-P) on anti-adipogenesis was evaluated.•LAB-P inhibited adipogenesis by inhibiting the key activators PPARγ and C/EBPα.•Its anti-adipogenic effect is related to the regulation of early adipogenic factors.•LAB-P suppresses lipid accumulation by regulating JAK/STAT and AMPKα signaling.
Paraprobiotics are non-viable cells or cell fractions that have beneficial effects on the host; they may help in overcoming the limitations of probiotics and expanding their benefits. Here, we aimed to investigate their effects on lipid accumulation and the underlying mechanisms in 3T3-L1 preadipocytes. A novel paraprobiotic, LAB-P, prepared from the live cells of Lactobacillus plantarum K8, effectively inhibited lipid accumulation during adipogenesis via downregulation of the key activators PPARγ and C/EBPα. LAB-P-mediated reduction of lipid accumulation regulated early adipogenic factors, including downregulation of C/EBPβ, KLF4, KLF5, KROX20, and C/EBPδ, and upregulation of DLK1. Western blotting analysis revealed that these inhibitory effects of LAB-P on adipogenesis were associated with regulating JAK-STAT and AMPKα signaling pathways. This study highlights the potential of paraprobiotics as a functional food material to control obesity or obesity-related diseases, and provides valuable groundwork for utilizing LAB-P as a functional ingredient to alleviate obesity or lipid accumulation. |
---|---|
ISSN: | 1756-4646 2214-9414 |
DOI: | 10.1016/j.jff.2021.104824 |